Livzon Pharmaceutical Group (SZSE:000513) Ending Cash Position : ¥10,788 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Ending Cash Position?

Livzon Pharmaceutical Group's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥10,788 Mil.

Livzon Pharmaceutical Group's quarterly Ending Cash Position increased from Sep. 2023 (¥9,996 Mil) to Dec. 2023 (¥10,976 Mil) but then declined from Dec. 2023 (¥10,976 Mil) to Mar. 2024 (¥10,788 Mil).

Livzon Pharmaceutical Group's annual Ending Cash Position increased from Dec. 2021 (¥9,125 Mil) to Dec. 2022 (¥10,073 Mil) and increased from Dec. 2022 (¥10,073 Mil) to Dec. 2023 (¥10,976 Mil).

Livzon Pharmaceutical Group Ending Cash Position Historical Data

The historical data trend for Livzon Pharmaceutical Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Ending Cash Position Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

8,854.19

9,952.05

9,125.31

10,072.64

10,976.37

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															10,600.47	10,484.93	9,995.85	10,976.37	10,787.98

Livzon Pharmaceutical Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Livzon Pharmaceutical Group's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10072.643	+	903.723
	=	10,976

Livzon Pharmaceutical Group's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10976.367	+	-188.392
	=	10,788

Livzon Pharmaceutical Group Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group (SZSE:000513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Ending Cash Position

Traded in Other Exchanges

01513:Hong Kong LP6:Germany

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines